18 2 19 Text word count: 3635 words 20 Abstract word count: 190 words 21 Number of figures: 4 22 Number of tables: 0 (Supplemental Table: 2) 23 Number of references: 69 3 25 Abstract 26 Apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like (APOBEC) DNA cytosine 27 deaminase 3B (A3B) is a DNA editing enzyme which induces genomic DNA mutations in 28 multiple myeloma and various other cancers. APOBEC family proteins are highly homologous 29 so it is especially difficult to investigate the biology of A3B alone in cancer cells. To investigate 30 A3B function in myeloma cells easily and comprehensively, we used CRISPR/Cas9 to generate 31 A3B reporter cells that contain 3×FLAG tag and IRES-EGFP sequences integrated at the end of 32 the A3B gene. These reporter cells stably express 3xFLAG tagged A3B and the reporter EGFP 33 and this expression is enhanced under known stimuli, such as PMA. Conversely, shRNA 34 knockdown of A3B decreased EGFP fluorescence and 3xFLAG tagged A3B protein levels. We 35 screened a series of anticancer treatments using these cell lines and identified that most 36 conventional therapies, such as antimetabolites or radiation, exacerbated endogenous A3B 37 expression, but recent molecular targeting drugs, including bortezomib, lenalidomide and 38 elotuzumab, did not. Furthermore, chemical inhibition of ATM, ATR and DNA-PK suppressed 39 the EGFP expression upon treatment with antimetabolites. These results suggest that DNA 40 damage response triggers A3B expression through ATM, ATR and DNA-PK signaling.
308 That is to say, these cell lines have the potential to clarify natural protein-protein and/or DNA-
